Marques-Vidal, Pedro published the artcile< Comparison of lifestyle changes and pharmacological treatment on cardiovascular risk factors>, Reference of 96829-58-2, the main research area is cardiovascular disease dyslipidemia diabetes hypertension LDL HDL orlistat glucose; diabetes; hypertension; lipoproteins and hyperlipidaemia; smoking cessation.
Cardiovascular disease is the leading cause of morbidity mortality in Europe and world wide. The major modifiable risk afactors are Obesity, Hypertension, Smoking, Dyslipidemia and Diabetes. In this paper, we will make a overview of the effect of life style changes on CVD rik factors and compare them with the effect of pharmacoogical treatment. Weight loss led to a consistent reduction in BP level, smoking cessation leads to an increase in BP levels. Potassium supplementation in Hypertensive subjects decreases BP levels. Any weight loss decreased low-d. lipoprotein(LDL)-cholesterol but had no effect on triglycerides. Drug induced weight loss led to a slight decrease in lipid levels, Orlistat exerting a stronger effect than other drugs. Weight loss decreased both plasma glucose and HbA1c. The risk factors of diabetes increased in the first 3 years after smoking cessation. A low-carbohydrate diet reduced HbA1c together with SBP and triglyceride levels, while increasing HDL-cholesterol levels in patients with diabetes. Adequately implemented, changes in lIfestyle acheive reductions in cardiovascular risk factors close to those of single-drug therapies.
Heart (London, United Kingdom) published new progress about Blood triglycerides Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 96829-58-2 belongs to class amides-buliding-blocks, and the molecular formula is C29H53NO5, Reference of 96829-58-2.
Referemce:
Amide – Wikipedia,
Amide – an overview | ScienceDirect Topics